본문
Bora Kang
Attorney
- TEL 82 2 6182 8166
- FAX 82 2 6003 7025
- E-MAIL brkang@yoonyang.com
Biography
Bora Kang is an associate at Yoon & Yang LLC and her main practice area is capital markets and finance, e.g. initial public offering (IPO) and listing on securities markets and KOSDAQ market, creation and management of collective investment schemes under the Financial Investment Services and Capital Markets Act and other special laws, withdrawal of private equity funds and derivatives, governance and regulations of business activities of financial companies, and the Trust Act, etc.
Ms. Kang has represented leading banks and securities companies of Korea in responding to financial sanctions related to suspension of redemption of private equity funds and addressing finance-related litigations such as class actions regarding securities, etc. Further, she has expertise in general corporate affairs including the corporate laws, corporate governance, due diligence and negotiations for M&As, and disputes regarding management rights, etc.
Ms. Kang has represented leading banks and securities companies of Korea in responding to financial sanctions related to suspension of redemption of private equity funds and addressing finance-related litigations such as class actions regarding securities, etc. Further, she has expertise in general corporate affairs including the corporate laws, corporate governance, due diligence and negotiations for M&As, and disputes regarding management rights, etc.
Experience
- 2018-present Yoon & Yang LLC
Education
- 2024 Seoul National University Business School, M.B.A.
- 2021 Seoul National University Graduate School of Law (LL.D. course completion)
- 2018 Seoul National University School of Law, J.D.
- 2015 Seoul National University, B.A. in Economics
Representative Matters
- Advised PAMTEK on KOSDAQ listing through reverse merger with SPAC
- Advised Bionote on KOSPI listing
- Advised SHIN Steel on KOSDAQ listing through reverse merger with SPAC
- Advised Soosan Industry on KOSPI listing
- Advised Lunit on KOSDAQ listing
- Advised Sungeel HiTech on KOSDAQ listing
- Advised ICH on KOSDAQ listing
- Advised Aprilbio on KOSDAQ listing
- Advised Hanwha Life on issuance of subordinated bonds
- Advised on Samsung C&T’s sale of its shares in Hanwha General Chemical
Awards
- Rising Star, Capital markets: Equity, IFLR1000 (2022-2024)
Insights
-
Admitted to bar, Korea (2018)
-
Korean and English